Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,315,490
+$15,987,477 QoQ
Shares Held
262,362
+710.9% QoQ
Ownership
0.768%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 239 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Derivatives in NKTR
reported options exposure · as of Dec 31, 2021CallValue
$104,027
CallShares
513
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. NKTR ranks #19 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in NKTR
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,315,490 | 262,362 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,328,013 | 32,356 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $652,971 | 15,444 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $949,034 | 16,679 | Shares | Defined | 2026-03-31 | |
| 2025-06-30 | $232,791 | 9,009 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $161,009 | 236,778 | Shares | Defined | 2026-03-17 | |
| 2024-12-31 | $303,010 | 325,818 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $465,782 | 358,294 | Shares | Defined | 2026-03-31 | |
| 2024-06-30 | $226,545 | 182,698 | Shares | Defined | 2026-03-23 | |
| 2024-03-31 | $532,866 | 572,975 | Shares | Defined | 2026-03-24 | |
| 2023-12-31 | $318,025 | 567,902 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $137,904 | 229,841 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $33,252 | 57,332 | Shares | Defined | 2026-03-27 | |
| 2023-03-31 | $106,926 | 152,754 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $370,414 | 163,900 | Shares | Defined | 2026-03-30 | |
| 2022-09-30 | $462,252 | 144,454 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $971,036 | 255,536 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,034,712 | 191,969 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,058,549 | 78,353 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $104,027 | 7,700 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $2,511,058 | 139,814 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $3,592,668 | 209,363 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $350,540 | 17,527 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $616,318 | 36,254 | Shares | Sole | 2021-02-11 | |
| 2020-12-31 | $428,400 | 25,200 | Call | Sole | 2021-02-11 | |
| 2020-12-31 | $503,200 | 29,600 | Put | Sole | 2021-02-11 | |
| 2020-09-30 | $491,064 | 29,600 | Put | Sole | 2020-11-12 | |
| 2020-09-30 | $3,427,658 | 206,610 | Shares | Sole | 2020-11-12 | |
| 2020-09-30 | $99,540 | 6,000 | Call | Sole | 2020-11-12 | |
| 2020-06-30 | $685,536 | 29,600 | Put | Sole | 2020-08-12 | |
| 2020-06-30 | $164,436 | 7,100 | Call | Sole | 2020-08-12 | |
| 2020-06-30 | $5,755,375 | 248,505 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,095,990 | 61,400 | Call | Sole | 2020-05-13 | |
| 2020-03-31 | $2,713,200 | 152,000 | Put | Sole | 2020-05-13 | |
| 2020-03-31 | $6,238,127 | 349,475 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||